home / stock / cmps / cmps articles


CMPS Articles, COMPASS Pathways Plc - From 04/01/24

Stock Information

Company Name: COMPASS Pathways Plc
Stock Symbol: CMPS
Market: NASDAQ
Website: compasspathways.com

Menu

CMPS CMPS Quote CMPS Short CMPS News CMPS Articles CMPS Message Board
Get CMPS Alerts

News, Short Squeeze, Breakout and More Instantly...

Compass Pathways to participate in upcoming 23rd Annual Needham Virtual Healthcare Conference | Benzinga

LONDON, April 01, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (NASDAQ:CMPS), a biotechnology company dedicated to accelerating patient access ...

Micron, Iris Energy, Trip.com Group And Other Big Stocks Moving Higher On Monday | Benzinga

U.S. stocks were lower, with the Dow Jones falling around 250 points on Monday. Shares of Micron Technology, Inc. (NASDAQ: MU) rose sharply during ...

Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More | Benzinga

Welcome to Benzinga’s psychedelic headlines roundup. This is our pick of must-read news items from the last two weeks of March 2024. See prev...

Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia Step Down from Board of Directors | Benzinga

LONDON, March 28, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (NASDAQ:CMPS) ("Compass"), a biotechnology company dedicated to accelerating pat...

MindMed Receives FDA 'Breakthrough Therapy' Designation For LSD As Anxiety Treatment, Shares Positive Results About Related Clinical Trials | Benzinga

Mind Medicine (MindMed) (NASDAQ:MNMD) announced that the FDA has granted the "breakthrough therapy" designation to its MM120 (lysergide d-tartrate)...

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session | Benzinga

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the company reported mixed fourth-quarter fin...

Podcast - Post-Frenzy Psychedelics Investing And Reclaiming The Right To Pursue Happiness With Zappy Zapolin: '2024 Is When It Goes Mainstream' | Benzinga

Welcome to a new episode of our Benzinga Psychedelics Podcast, this time joined by business trendspotter and "psychedelics concierge" Zappy Zapolin...

Compass Pathways to announce fourth quarter and year-end 2023 financial results on February 29, 2024 | Benzinga

LONDON, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (NASDAQ:CMPS), a biotechnology company dedicated to accelerating patient access t...

Compass Pathways to participate in upcoming Oppenheimer investor conference | Benzinga

LONDON, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Compass Pathways plc (NASDAQ:CMPS), a biotechnology company dedicated to accelerating patient access t...

Psychedelics Headlines: MDMA & Coping Skills In PTSD, LSD's Perceived Risks, Knowledge Gaps, Surveys & More | Benzinga

Welcome to Benzinga's weekly psychedelics headlines roundup. This is our pick of must-read news items from the second week of January 2024.&nbs...

Previous 10 Next 10